Learn more

PROBIODRUG GES FUER ARZNEIM

Overview
  • Total Patents
    35
About

PROBIODRUG GES FUER ARZNEIM has a total of 35 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are POTISEK STEPHANIE L, MOSKAL JOSEPH and BACHOVCHIN WILLIAM W.

Patent filings per year

Chart showing PROBIODRUG GES FUER ARZNEIMs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Demuth Hans-Ulrich 31
#2 Schlenzig Dagmar 16
#3 Hoffmann Torsten 16
#4 Glund Konrad 15
#5 Kruber Susanne 10
#6 Schmidt Joern 7
#7 Manhart Susanne 6
#8 Heiser Ulrich 3
#9 Rosche Fred 2
#10 Mcintosh Christopher H S 1

Latest patents

Publication Filing date Title
DE19940130A1 New effectors of Dipeptidyl Peptidase IV for topical use
CZ20004796A3 Compounds of unstable DP IV-inhibitors
CZ20004764A3 Precursors of DP IV-inhibitors
DE19926233C1 Production of thiazolidine, useful as pharmaceutical intermediate, comprises reacting hexamethylenetetramine with cysteamine
CZ20004427A3 Novel effectors of IV dipeptidyl peptidase
DE19834591A1 Use of substances that decrease the activity of dipeptidyl peptidase IV to increase blood sugar levels, e.g. for treating hypoglycemia
DE19834610A1 New N-dipeptidyl O-acyl hydroxylamine derivatives useful as dipeptidyl peptidase I inhibitors, e.g. for treating cancer or immunological or metabolic disorders
DE19828113A1 Prodrugs of Dipeptidyl Peptidase IV Inhibitors
DE19828114A1 Produgs of unstable inhibitors of dipeptidyl peptidase IV
DE19823831A1 New pharmaceutical use of isoleucyl thiazolidide and its salts